The Optimum Perspectives Podcast
New episode! Listen as Optimum’s Eva Haas and Richard Staines discuss the hot areas for investment in the shifting biotech market – including antibody-drug conjugates, smart radiotherapies, mRNA and immune-oncology.
26 September 2023
Insights from Optimum’s 15th Annual Healthcare Investor Conference 2023
Optimum celebrated its 15th Annual Healthcare Investor Conference on Wednesday 11 October at the Wellcome Trust, London – marking its crystal anniversary – and what a sparkler it was! Check out our panel summaries to learn more or to rediscover insights from the day.
26 October 2023
The ‘must-attend’ Healthcare conferences Autumn / Winter 2023
Sachs, LSX, Genesis and more… As an official supporter to many of the top events, Optimum is pleased to be able to provide discount codes to its network.
15 September 2023
Insights
We’d love to hear from you
For more information about Optimum Strategic Communications, please get in touch.
MiFID II and Consensus numbers, what does it mean for IR teams?
/in InsightsLiving In The MIFID World – THURSDAY, 14 JUNE 2018
/in InsightsHighlights from the 9th Annual Healthcare Investor Conference at Bloomberg
/in InsightsCurrent public market environment and equity investor views
/in InsightsBiotech is “hot” and M&A deals are likely to be an ongoing feature of the industry
/in InsightsScaling up a Company to $10bn-$20bn
/in Insights